Decreased Sirtuin1 Protein and Aromatase Activity Index in Follicular Fluid is Correlated with Increased Germinal Vesicle Count in Polycystic Ovary Syndrome

多囊卵巢综合征患者卵泡液中Sirtuin1蛋白和芳香化酶活性指数降低与生发泡数量增加相关

阅读:1

Abstract

The close interaction of follicular fluid with oocytes influences their maturation. The presence of the germinal vesicle (GV) has been reported in women with polycystic ovary syndrome (PCOS). The present study aimed to measure sirtuin1 (SIRT1) levels, aromatase activity index and insulin resistance in follicular fluid and to investigate their association with in vitro fertilization (IVF) success in PCOS women. In this case-control study, 35 women with PCOS and 35 healthy women matched for body mass index (BMI) were included. After the collection of the follicular fluid from all participants, concentrations of SIRT1, insulin, and aromatase activity were measured. Retrieved oocyte status, embryo quality, and biochemical pregnancy were monitored during follow-up in the participants. In women with PCOS, there were notable reductions in SIRT1 levels and aromatase activity, along with an increase in the HOMA- Index. Negative correlations were observed between SIRT1 and aromatase activity with the number of GVs. SIRT1 concentration and aromatase activity showed positive correlation with the ratio of available embryos to the number of oocytes in metaphase II. Logistic regression analysis showed that chance of biochemical pregnancy increases significantly with an increase in aromatase activity and SIRT1 level in follicular fluid (p<0.05). Our findings showed that the reduced SIRT1 level and aromatase activity in follicular fluid are involved with the pathogenesis of PCOS. These findings suggest that increasing in aromatase activity and SIRT1 levels may improve oocytes quality and ultimately increase the chances of IVF success in PCOS women.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。